UY32905A - USE OF A QUINOLONE DERIVATIVE CONTAINING A 7- (4-AMINOMETIL-3- OXIMA) PYRROLIDINE GROUP THAT IS CAPABLE OF INDUCING THE COLONY-STIMULATING FACTOR OF GRANULOCITES FOR THE TREATMENT OF NEUTROPENIA AND THE RECOVERY OF HEMATOPOIESIS - Google Patents
USE OF A QUINOLONE DERIVATIVE CONTAINING A 7- (4-AMINOMETIL-3- OXIMA) PYRROLIDINE GROUP THAT IS CAPABLE OF INDUCING THE COLONY-STIMULATING FACTOR OF GRANULOCITES FOR THE TREATMENT OF NEUTROPENIA AND THE RECOVERY OF HEMATOPOIESISInfo
- Publication number
- UY32905A UY32905A UY0001032905A UY32905A UY32905A UY 32905 A UY32905 A UY 32905A UY 0001032905 A UY0001032905 A UY 0001032905A UY 32905 A UY32905 A UY 32905A UY 32905 A UY32905 A UY 32905A
- Authority
- UY
- Uruguay
- Prior art keywords
- neutropenia
- treatment
- recovery
- granulocites
- aminometil
- Prior art date
Links
- 208000004235 neutropenia Diseases 0.000 title abstract 2
- 238000011084 recovery Methods 0.000 title abstract 2
- 102000007644 Colony-Stimulating Factors Human genes 0.000 title 1
- 108010071942 Colony-Stimulating Factors Proteins 0.000 title 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 title 1
- 230000011132 hemopoiesis Effects 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 150000007660 quinolones Chemical class 0.000 title 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 abstract 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 239000003306 quinoline derived antiinfective agent Substances 0.000 abstract 1
- -1 quinolone antibiotic compound Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a un compuesto antibiótico de quinolona de fórmula (1) capaz de promover la producción de G-CSF en el cuerpo y al . medicamento para el tratamiento de la neutropenia y la recuperación tempranaThe present invention relates to a quinolone antibiotic compound of formula (1) capable of promoting the production of G-CSF in the body and al. medication for the treatment of neutropenia and early recovery
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20090092074 | 2009-09-28 | ||
| KR20090092636 | 2009-09-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY32905A true UY32905A (en) | 2011-12-01 |
Family
ID=43796408
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001032905A UY32905A (en) | 2009-09-28 | 2010-09-27 | USE OF A QUINOLONE DERIVATIVE CONTAINING A 7- (4-AMINOMETIL-3- OXIMA) PYRROLIDINE GROUP THAT IS CAPABLE OF INDUCING THE COLONY-STIMULATING FACTOR OF GRANULOCITES FOR THE TREATMENT OF NEUTROPENIA AND THE RECOVERY OF HEMATOPOIESIS |
Country Status (5)
| Country | Link |
|---|---|
| KR (1) | KR20110034566A (en) |
| AR (1) | AR078453A1 (en) |
| TW (1) | TW201121965A (en) |
| UY (1) | UY32905A (en) |
| WO (1) | WO2011037433A2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9079922B2 (en) | 2011-11-08 | 2015-07-14 | Actelion Pharmaceuticals Ltd | 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives |
| AR096135A1 (en) | 2013-05-02 | 2015-12-09 | Actelion Pharmaceuticals Ltd | DERIVATIVES OF QUINOLONA |
| WO2021009212A1 (en) | 2019-07-16 | 2021-01-21 | Idorsia Pharmaceuticals Ltd | Antibacterial quinolone derivatives |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004017925A2 (en) * | 2002-08-23 | 2004-03-04 | Genome Therapeutics Corporation | Methods and reagents for preventing bacteremias |
| US20040127403A1 (en) * | 2002-09-06 | 2004-07-01 | Francesco Parenti | Methods for treating and preventing Gram-positive bacteremias |
-
2010
- 2010-09-23 TW TW099132151A patent/TW201121965A/en unknown
- 2010-09-27 AR ARP100103492A patent/AR078453A1/en not_active Application Discontinuation
- 2010-09-27 UY UY0001032905A patent/UY32905A/en not_active Application Discontinuation
- 2010-09-27 KR KR1020100093471A patent/KR20110034566A/en not_active Withdrawn
- 2010-09-27 WO PCT/KR2010/006559 patent/WO2011037433A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| KR20110034566A (en) | 2011-04-05 |
| WO2011037433A2 (en) | 2011-03-31 |
| WO2011037433A3 (en) | 2011-09-09 |
| AR078453A1 (en) | 2011-11-09 |
| TW201121965A (en) | 2011-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN01755A (en) | ||
| BRPI0921701B8 (en) | Cepharosporin having a catechol group, its use and pharmaceutical composition comprising it | |
| CO6680667A2 (en) | Ester derivatives of cyclic boronic acid and its therapeutic uses | |
| BR112012008889A2 (en) | spiropiperidine compounds and pharmaceutical use thereof to treat diabetes | |
| IN2014MN02106A (en) | ||
| JO3111B1 (en) | Substituted triazolopyridines and their use as ttk inhibitors | |
| MX2011013306A (en) | Tetracyclic compound. | |
| MX378354B (en) | IMPROVEMENT OF AUTOPHAGY OR INCREASE IN LONGEVITY BY ADMINISTRATION OF UROLITINS OR PRECURSORS THEREOF. | |
| EP2581376A4 (en) | MATRIC ACID / MATRIN DERIVATIVES AND MANUFACTURING METHOD AND USES THEREOF | |
| BR112012012903A2 (en) | spiropiperidine compounds | |
| BRPI1004899B8 (en) | phosphoinositide 3-kinase inhibitor compound, pharmaceutical composition and use of a compound | |
| NI200900081A (en) | PEPTIDOMMETIC SMAC USEFUL AS IAP INHIBITORS | |
| NZ627274A (en) | Anesthetic compounds and related methods of use | |
| JO3040B1 (en) | Triazolopyridines | |
| AR058098A1 (en) | DERIVATIVES OF DICARBOXYL ACIDS AND THEIR USE | |
| BR112013007380A2 (en) | nitrocathecol administration regimen | |
| IN2012DN02502A (en) | ||
| BR112015004523A2 (en) | tetracycline compounds | |
| PE20142450A1 (en) | DIFLUORO-HEXAHYDRO-CYCLOPENTAOXACINYLS AND DIFLUORO-HEXAHYDRO-BENZOOXACINYLS AS BACE1 INHIBITORS | |
| BR112015014433A2 (en) | tricyclic compounds | |
| MX2013002620A (en) | Novel n-hydroxy-benzamides for the treatment of cancer. | |
| UY32905A (en) | USE OF A QUINOLONE DERIVATIVE CONTAINING A 7- (4-AMINOMETIL-3- OXIMA) PYRROLIDINE GROUP THAT IS CAPABLE OF INDUCING THE COLONY-STIMULATING FACTOR OF GRANULOCITES FOR THE TREATMENT OF NEUTROPENIA AND THE RECOVERY OF HEMATOPOIESIS | |
| IN2013DN02555A (en) | ||
| IN2014DN11023A (en) | ||
| AR076709A1 (en) | PIPERIDINS REPLACED AS PAR-1 ANTAGONISTS AND A PROCEDURE FOR THEIR PREPARATION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20190222 |